Cancer(neoplasm). Neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with cancer over 18 years of age who report fatigue in their daily life activities Patients must have the oncologist's permission to start exercising Participants should not have conditions that prevent them from doing exercises; including cardiovascular diseases (uncontrolled high blood pressure, arrhythmia and aortic aneurysm), respiratory diseases (chronic obstructive pulmonary disease, pulmonary hypertension, severe dyspnea) Participants should not have uncontrolled lymphedema, fever, or uncontrolled active infection (based on clinical observations and medical record review) Participants should not have cognitive dysfunction (score below 24 on the MMSE test) Participants should not have major anxiety disorders or major depression; (HADS-D =11) and (HADS-A =11) Participants should not have diabetes, brain or bone metastases. Participants must be able to walk independently Participants must have the ability to understand the research objectives and fill in the questionnaires in Persian language Participants should not be evaluated or receive exercises for 24 hours after chemotherapy.
Exclusion criteria
Exclusion criteria: Lack of attendance and participation to complete treatment sessions (more than 2 sessions) Simultaneous use of other rehabilitation services (occupational therapy or physiotherapy) or professional sports Recurrence of cancer during the time of intervention and changes in patients' drugs and treatment regimen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer Related Fatigue. Timepoint: Before the intervention, after the intervention and 6 weeks after the end of the intervention. Method of measurement: Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-Fatigue) Questionnaire and Multi Dimensional Fatigue(MFI) Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before the intervention, after the intervention and 6 weeks after the end of the intervention. Method of measurement: The Short Form Health Survey (SF-12).;Engagement in Meaningful Activities. Timepoint: Before the intervention, after the intervention and 6 weeks after the end of the intervention. Method of measurement: Engagement in Meaningful Activities Survey (EMAS).;Independence in daily life activities. Timepoint: Before the intervention, after the intervention and 6 weeks after the end of the intervention. Method of measurement: Lawton Instrumental Activities of Daily Living Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences